BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31888644)

  • 1. Directional association test reveals high-quality putative cancer driver biomarkers including noncoding RNAs.
    Zhong H; Song M
    BMC Med Genomics; 2019 Dec; 12(Suppl 7):129. PubMed ID: 31888644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fast exact functional test for directional association and cancer biology applications.
    Zhong H; Song M
    IEEE/ACM Trans Comput Biol Bioinform; 2018 Feb; ():. PubMed ID: 29993984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNAs and Colorectal Cancer: A General Overview.
    Sarraf JS; Puty TC; da Silva EM; Allen TSR; Sarraf YS; de Carvalho LEW; Adami F; de Oliveira EHC
    Microrna; 2020; 9(5):336-345. PubMed ID: 33349228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense Transcription in Loci Associated to Hereditary Neurodegenerative Diseases.
    Zucchelli S; Fedele S; Vatta P; Calligaris R; Heutink P; Rizzu P; Itoh M; Persichetti F; Santoro C; Kawaji H; Lassmann T; Hayashizaki Y; Carninci P; Forrest ARR; ; Gustincich S
    Mol Neurobiol; 2019 Aug; 56(8):5392-5415. PubMed ID: 30610612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between regulation by methylation and noncoding RNAs in cancers.
    Lu CX; Wu XL; Zhang GY; Gu XT; Ma X; He DX
    Eur J Cancer Prev; 2018 Jul; 27(4):418-424. PubMed ID: 29557800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the transcriptional regulatory networks of promoter-associated noncoding RNAs in development and cancer.
    Chellini L; Frezza V; Paronetto MP
    J Exp Clin Cancer Res; 2020 Mar; 39(1):51. PubMed ID: 32183847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cancer long non-coding RNA transcriptomes.
    Gibb EA; Vucic EA; Enfield KS; Stewart GL; Lonergan KM; Kennett JY; Becker-Santos DD; MacAulay CE; Lam S; Brown CJ; Lam WL
    PLoS One; 2011; 6(10):e25915. PubMed ID: 21991387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNCDatabase: a database of non-coding cancer drivers.
    Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
    Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-coding transcriptome as a dynamic regulator of cancer metastasis.
    Crea F; Clermont PL; Parolia A; Wang Y; Helgason CD
    Cancer Metastasis Rev; 2014 Mar; 33(1):1-16. PubMed ID: 24346158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNA transcription targets AID to divergently transcribed loci in B cells.
    Pefanis E; Wang J; Rothschild G; Lim J; Chao J; Rabadan R; Economides AN; Basu U
    Nature; 2014 Oct; 514(7522):389-93. PubMed ID: 25119026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).
    Yang G; Wu Y; Wan R; Sang H; Liu H; Huang W
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34296296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer.
    Chen B; Huang S
    Cancer Lett; 2018 Apr; 418():41-50. PubMed ID: 29330104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
    Garajová I; Balsano R; Tommasi C; Giovannetti E
    Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
    Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
    Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.
    Deng Y; Luo S; Zhang X; Zou C; Yuan H; Liao G; Xu L; Deng C; Lan Y; Zhao T; Gao X; Xiao Y; Li X
    Mol Oncol; 2018 Nov; 12(11):1980-2005. PubMed ID: 30216655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between N
    Chen Y; Lin Y; Shu Y; He J; Gao W
    Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.